Updates in Hepatocellular Carcinoma: Clinical Decision-making Among an Array of New Options

Updates in Hepatocellular Carcinoma: Clinical Decision-making Among an Array of New Options

Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide a…

Expiration Date: 5/23/2020

Max Credits: 0.75

View Activity

Applying Checkpoint Inhibitors in NSCLC and SCLC: A Symposium at HEMONC Today New York

Applying Checkpoint Inhibitors in NSCLC and SCLC: A Symposium at HEMONC Today New York

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 5/12/2020

Max Credits: 0.75

View Activity

The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

For patients diagnosed with metastatic melanoma, the lifetime incidence of…

Expiration Date: 4/30/2020

Max Credits: 1

View Activity

Optimizing Multiple Myeloma Treatment Selection in Your Community Oncology Practice

Optimizing Multiple Myeloma Treatment Selection in Your Community Oncology Practice

The approval and integration of several novel therapeutic agents into the …

Expiration Date: 1/6/2020

Max Credits: 0.75

View Activity

Clinical Advances in Cutaneous T-cell Lymphoma: What You Need to Know About a Rare Malignancy

Clinical Advances in Cutaneous T-cell Lymphoma: What You Need to Know About a Rare Malignancy

Cutaneous T-cell lymphoma (CTCL) is a rare and heterogeneous type of T-cel…

Expiration Date: 1/6/2020

Max Credits: 0.75

View Activity

The CME Situation Room: How Will Biosimilars Impact Oncology Care?

The CME Situation Room: How Will Biosimilars Impact Oncology Care?

Biosimilars are highly similar, yet not identical, biological products for…

Expiration Date: 8/12/2019

Max Credits: 1

View Activity

EGFR T790M-Mutated NSCLC: The Latest on Testing and Treating

EGFR T790M-Mutated NSCLC: The Latest on Testing and Treating

Lung cancer is a leading cause of cancer death worldwide. The American Can…

Expiration Date: 5/10/2019

Max Credits: 0

View Activity

Decisions, Decisions: Differentiating Checkpoint Inhibitors for Bladder Cancer

Decisions, Decisions: Differentiating Checkpoint Inhibitors for Bladder Cancer

The integration of immune checkpoint inhibitors into treatment algorithms …

Expiration Date: 5/8/2019

Max Credits: 0

View Activity

Immuno-Oncology Forum III: Focus on NSCLC

Immuno-Oncology Forum III: Focus on NSCLC

The rapid evolution and integration of immune checkpoint inhibitors into t…

Expiration Date: 2/28/2019

Max Credits: 0

View Activity

Immune Checkpoint Inhibitors for Bladder Cancer: Practice Essential for Community Oncologists and Advanced Practice Providers

Immune Checkpoint Inhibitors for Bladder Cancer: Practice Essential for Community Oncologists and Advanced Practice Providers

For many years, the mainstay of initial treatment for metastatic bladder c…

Expiration Date: 2/23/2019

Max Credits: 0

View Activity